Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
DAL arrives at its October 9 earnings release with options positioning still tilted bullishly, short interest continuing its retreat, and a lending market that remains almost frictionless, though the analyst community has quietly shifted to a more cautious tone since the previous note published on September 26.
The bull-leaning setup from last week has held broadly intact, with some nuance. The put/call ratio edged up to 0.56 on October 5 from the 52-week low of 0.52 hit earlier in the period, but it remains well below its 20-day average of 0.68 and roughly 0.6 standard deviations below that mean. Call positioning still dominates. Short interest has continued to ease, now at 3.4% of the free float and down another 3% in a single session on October 2, extending the retreat from the mid-September peak near 27.3 million shares. Availability in the borrow market has widened further to 1,818% of outstanding short interest, meaning there is more than 18 times as much stock available to lend as there are shares currently borrowed. Borrow cost ticked up 13% over the past week to 0.47%, but that remains firmly in "low" territory and well within normal range for a large-cap liquid name. The stock itself is flat on the week at $83.08, up around 3.6% over the past month.
The more meaningful development since the last article is how the analyst consensus has moved. The direction of travel is clearly lower on price targets, even as ratings have held. TD Cowen cut its target to $101 from $105 on October 2, one day before the print window, maintaining Buy. BMO Capital similarly trimmed to $100 from $105 on September 28. The counter-move came from UBS, which raised its target to $105 from $99 on September 24, citing a more constructive view on unit revenue trends. Barclays made the sharpest cut in the window, dropping to $95 from $105 on September 11 while keeping Overweight. The mean target of roughly $102 still implies around 22% upside to the current price, and no firm has downgraded the rating itself. Bulls are pointing to premium cabin resilience and Delta's balance sheet relative to peers; bears are focused on fuel and labor cost pressure squeezing margins in Q3, an angle reinforced by softer corporate travel commentary flagged in recent analyst notes.
Berkshire Hathaway remains the standout in the ownership register. Warren Buffett's firm filed a 13G/A in August disclosing its stake had grown to 8.7% from 6.1% previously, adding roughly 57.3 million shares as last disclosed. That filing is now around seven weeks old, and 13D/G positions are event-driven disclosures, stakes are as-last-disclosed around the 5% threshold and a holder can reduce without filing again. But the direction of Buffett's move, buying rather than trimming into a period when most analysts were cutting targets, is one of the more distinctive ownership signals in the group. Among airline peers, UAL fell 1.4% on the week and AAL dropped 5.1%, making DAL's relative stability more notable than it looks in absolute terms.
The October 9 print will test whether Delta's premium revenue mix and cost discipline can hold margins close enough to prior guidance to justify a stock that has re-rated higher while most of its peers have pulled back, and whether the retreat in short interest and the call-heavy options book reflect genuine conviction or simply a lack of fresh reasons to bet the other way.
See the live data behind this article on ORTEX.
Open DAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
